NICOX

Company Listings from SPi: NICOX

You are here: Home >> SPi Company Listings >> NICOX

 

NICOX

Website:
http://

Search for other references to "nicox" on SPi News

Latest NICOX News

Nicox: Number of voting rights 31 May 2019 Head Office:DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642On June 3, 2019,---------------Phone: +33 4-97-24-53-00Fax : +33  4-97-24-5...... 17:00 GMT Monday 3rd June 2019

Dr. Thomas Walters Presents Update on Nicox’s NCX 470 Phase 2 Clinical Study in Podium Presentation at ASCRS 2019  ...... 06:30 GMT Monday 6th May 2019

Nicox Presents First Data on Promising New Class of Nitric Oxide (NO)-Donating Compounds for Glaucoma at the ARVO 2019 Annual Meeting  ...... 06:30 GMT Friday 3rd May 2019

Nicox: Number of voting rights 30 April 2019 Head Office:DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642On May 2, 2019,---------------Phone: +33 4-97-24-53-00Fax : +33  4-97-24-53...... 17:00 GMT Thursday 2nd May 2019

Nicox to Present at Upcoming Pharmaceutical Industry and Financial Events ...... 06:30 GMT Monday 29th April 2019

Nicox: Number of voting rights as of 24 April 2019 Head Office:DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642On April 24, 2019,---------------Phone: +33 4-97-24-53-00Fax : +33  4-97-24...... 17:00 GMT Wednesday 24th April 2019

Nicox First Quarter 2019 Business Update and Financial Highlights Nicox First Quarter 2019 Business Update and Financial Highlights Key Upcoming Milestones First Quarter 2019 and Recent Operational Highlights As of March 31, 2019, the Nicox Gro...... 06:30 GMT Thursday 18th April 2019

Nicox Initiates Phase 2 Trial of NCX 4251 in Blepharitis  Nicox Initiates Phase 2 Trial of NCX 4251 in BlepharitisThis Phase 2 multi-center, randomized, double-masked, placebo-controlled, dose-escalation, 14-day trial aims to evaluate...... 06:31 GMT Tuesday 19th March 2019

Nicox Poster Presentation at AGS 2019 Annual Meeting Discloses Preclinical Data for NCX 4251, a Novel Blepharitis Therapy Nicox Poster Presentation at AGS 2019 Annual Meeting Discloses Preclinical Data for NCX 4251, a Novel Blepharitis Therapy March 18, 2019 - release at 7:30 am CET Sophia Antipolis...... 06:31 GMT Monday 18th March 2019

Nicox signs agreement for ZERVIATE in China for up to €17 million in milestone payments plus royalties Nicox signs agreement for ZERVIATE in China for up to €17 million in milestone payments plus royalties Ocumension will receive exclusive rights for the agreed territory to develo...... 06:31 GMT Friday 15th March 2019

Buy NICOX
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us